The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
ESMO Asia 2025 | Single-port surgery advances for mediastinal tumor resection in lung cancer
Jazmin Eckhaus, MBBS, FRACS, St Vincent’s Hospital, Melbourne, Australia, describes the impact of technological advancements on surgical practices in lung cancer, highlighting the ability to remove reasonably sized mediastinal tumors through a single-port system with a small incision. This shift is not only driven by technology, but also by a change in mindset and the willingness to push boundaries, leading to improved patient outcomes. This interview took place at 2025 European Society for Medical Oncology (ESMO) Asia Congress in Singapore, Singapore.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Transcript
And what we’re seeing is this is really a technology-driven change primarily, but also I think we’re really changing what we think we can do and what we think we can achieve. I think I’ve seen that mostly with patients who have mediastinal tumors where we’re now able to use a single-port system and patients can have not huge but reasonably sized tumors removed through a three-centimeter cut below their sternum and I think part of it requires that technology but the other part is to accept and have that belief that you can do this ridiculous thing for people and I hope that we’re going to continue to see all these amazing technological advances because you really do see it translate into better patient outcomes...
And what we’re seeing is this is really a technology-driven change primarily, but also I think we’re really changing what we think we can do and what we think we can achieve. I think I’ve seen that mostly with patients who have mediastinal tumors where we’re now able to use a single-port system and patients can have not huge but reasonably sized tumors removed through a three-centimeter cut below their sternum and I think part of it requires that technology but the other part is to accept and have that belief that you can do this ridiculous thing for people and I hope that we’re going to continue to see all these amazing technological advances because you really do see it translate into better patient outcomes.
This transcript is AI-generated. While we strive for accuracy, please verify this copy with the video.
Read more...
